CancerNetwork® Inaugural Face-Off Contemporary Concepts in Hematologic Oncology Real-World Evidence in NSCLC Guides Clinical Decisions Register: ctDNA in Treatment Decisions and Response Monitoring Targeting NSCLC with Uncommon EGFR Mutations

CancerNetwork® Inaugural Face-OffContemporary Concepts in Hematologic OncologyReal-World Evidence in NSCLC Guides Clinical Decisions Register: ctDNA in Treatment Decisions and Response MonitoringTargeting NSCLC with Uncommon EGFR Mutations

Clinical

View More Acute Myeloid Leukemia Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Acute Myeloid LeukemiaBrain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

Clinical Topics Integrative Care Global Bulletin All News Approval Alert

Clinical TopicsIntegrative CareGlobal BulletinAll NewsApproval Alert

Media

2 Minute Drill Around the Practice Between the Lines Clinical Consult Expert Interviews Face Off Medical World News OncView Podcasts Readout 360 Year in Review

2 Minute DrillAround the PracticeBetween the LinesClinical ConsultExpert InterviewsFace OffMedical World NewsOncViewPodcastsReadout 360Year in Review

Conferences

Publications

All Journals For Authors Tumor Board

All JournalsFor AuthorsTumor Board

CME/CE

Resources

Contemporary Concepts Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored

Contemporary ConceptsInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

CancerNetwork® Inaugural Face-Off
Contemporary Concepts in Hematologic Oncology
Real-World Evidence in NSCLC Guides Clinical Decisions
Register: ctDNA in Treatment Decisions and Response Monitoring
Targeting NSCLC with Uncommon EGFR Mutations

ClinicalSee All >

Acute Myeloid Leukemia
Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Cara Mathews, MD | Authors

Cara Mathews, MD, Talks Dostarlimab for Advance Recurrent Endometrial Cancers

April 01, 2022

Cara Mathews, MD, spoke with CancerNetwork® about research examining dostarlimab vs doxorubicin for patients with mismatch repair–deficient endometrial cancers.